Tirzepatide is a synthetic dual GLP-1/GIP receptor peptide API developed for research applications. By targeting both GLP-1 and GIP pathways, Tirzepatide represents an advanced peptide platform for metabolic research studies. Our Tirzepatide API is supplied as a high-purity lyophilized powder and manufactured under strict quality control standards. Each batch undergoes comprehensive analytical testing to ensure consistency, reliability, and traceability. Batch-specific documentation, quality reports, and COA files are available to support research and development requirements.